From Name

From Email

To Name

To Email

Message

CMS Proposed Rule Aims to Foster More Medicaid Value-Based Drug Agreements

from Fierce Healthcare

CMS Proposed Rule Aims to Foster More Medicaid Value-Based Drug Agreements Fierce Healthcare The Trump administration issued a proposed rule intended to remove barriers to develop value-based purchasing agreements between states and drug companies. The Centers for Medicare & Medicaid Services’ final rule gives states more flexibility to enter into value-based purchasing agreements with drug makers for new and pricey products. The rule also creates minimum standards for Medicaid drug utilization programs intended to combat opioid fraud and misuse. READ MORE

more